Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Feng-Hua Pei"'
Publikováno v:
OncoTargets and therapy
Aiyun Liu,1 Jiutao Qiao,2 Liyuan He,1 Zhangmeng Liu,1 Jing Chen,1 Fenghua Pei,1 Yaju Du1 1Department of Gastroenterology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China; 2Department of Orthopedics, T
Publikováno v:
Molecular Medicine Reports
Bortezomib, a first‑in‑class proteasome inhibitor, is a standard method of treatment in multiple myeloma. In the present study, the therapeutic effect of bortezomib was evaluated in an ulcerative colitis model induced by dextran sulfate sodium (D
Publikováno v:
Molecular Medicine Reports
Among the various consequence arising from lung injury, hepatic fibrosis is the most severe. Decreasing the effects of hepatic fibrosis remains one of the primary therapeutic challenges in hepatology. Dysfunction of hepatic sinusoidal endothelial cel
Autor:
Bing-Rong Liu, An-Chao Zhu, Yan-Fen Zhang, Hui Li, Bao-Shan Yang, Feng-Hua Pei, Xiao-Ren Wang, Bing-Zhu Yan
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 15:73-80
Background Acute liver failure (ALF) is a severe and life-threatening clinical syndrome resulting in a high mortality and extremely poor prognosis. Recently, a water-soluble CO-releasing molecule (CORM-3) has been shown to have anti-inflammatory effe
Publikováno v:
Microbial pathogenesis. 125
Liver injury is an important cause of serious liver disease and is characterized by inflammatory and oxidative responses. Esculin, a coumarinic derivative found in Aesculus hippocastanum L., has been shown to exhibit anti-inflammatory and anti-oxidat
Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells
Publikováno v:
Oncology Letters. 10:3682-3688
5-Fluorouracil (5-FU) is the chemotherapeutic drug of choice for the treatment of metastatic colorectal cancer (CRC). Tumor suppressor candidate 4 (TUSC4), also referred to as nitrogen permease regulator-like 2 (NPRL2), is located at chromosome 3p21.
Autor:
Ji‑Tao Song, Jing Chen, Hang‑Yu Wang, Feng‑Hua Pei, Qi You, Jun Xu, Ling‑Jian Kong, Feng‑Dong Li, Dian‑Gang Liu
Publikováno v:
Molecular Medicine Reports. 12:5594-5600
The aim of the present study was to detect the effect of the recombinant human endostatin Endostar on hepatic sinusoidal capillarization in CCl4‑induced murine models of liver fibrosis. The liver fibrosis model was induced in BALB/c mice using intr
Autor:
Hang-Yu Wang, Yu-jing Fan, Ling-Jian Kong, Jing Chen, Ya-Ju Du, Diangang Liu, Feng-Hua Pei, Feng-Dong Li, Ai-Yun Liu, Xin-Hong Wang, Ji-Tao Song, Guang Yang, Bao-Xin Li
Publikováno v:
Experimental Biology and Medicine. 239:998-1006
Decreasing hepatic fibrosis remains one of the major therapeutic challenges in hepatology. The present study aims to evaluate the effect of Endostar on both CCl4-induced liver fibrosis in mice and a hepatic stellate cell (HSC) line. Two main models w
Autor:
Ying-zhun Chen, Feng-Hua Pei, Bing-Rong Liu, Yu-jing Fan, Dian-Ggang Liu, Xin-Hong Wang, Ai-Yun Liu, Ya-Ju Du, Yang Jiang, Jing Chen, Hui-tao Zhang, Guang Yang
Publikováno v:
Cancer Biology & Therapy. 15:489-495
NPRL2 is a tumor suppressor gene involved in the progression of human cancer. The present study investigated whether NPRL2 expression correlates with colorectal cancer (CRC) progression. Colorectal tissue and peripheral blood samples were obtained fr
Autor:
Su-Qin Liu, Feng-Hua Pei, Zhendong Chen, Xin-Hong Wang, Lixia Zhao, Yanyan Song, Bing-Rong Liu, Deliang Li
Publikováno v:
Oncotarget
// Suqin Liu 1,2 , Fenghua Pei 1 , Xinhong Wang 1 , Deliang Li 1 , Lixia Zhao 1 , Yanyan Song 1 , Zhendong Chen 1 and Bingrong Liu 1 1 Department of Gastroenterology and Hepatology, The Second Affiliated Hospital of Harbin Medical University, Harbin,